SUN PHARMA - Company Intelligence Profile
Industry: Pharmaceutical Manufacturing | Founded: 1983 | HQ: Mumbai, India
Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents,...
Datakart tracks firmographic, hiring, traffic, technology, funding, review, and leadership signals for SUN PHARMA to help teams evaluate the account with useful business context.
Public Company
SUN PHARMA
sunpharma.com
Employees
46.2K
Monthly visits
240.9K
Open roles
414
Search volume
110K
Company Snapshot
Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues.
At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come.
With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/
Founded
Employee count
Monthly website visits
Open roles
Company Snapshot Details
Business signals that help qualify SUN PHARMA
This profile combines firmographic, traffic, hiring, employee, review, compensation, technology, funding, leadership, and product availability signals so visitors can answer practical business questions without hunting across multiple data sources.
Last refreshed 2026-04-29 | 110K search volume | Domain sunpharma.com
SUN PHARMA identity, aliases, ownership, and taxonomy
This section makes the entity easier to verify: canonical domains, alternate names, descriptions, ownership flags, parent or acquirer context, industry codes, and source-level social reach are grouped together.
Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/
Sun Pharma is the fourth largest global specialty generic pharmaceutical company with a presence in more than 100 countries. They focus on innovation, quality, and responsibility in providing healthcare solutions.
LinkedIn followers
2.3M
Latest linkedin followers value available from the source dataset.
Owler followers
1.4K
Latest owler followers value available from the source dataset.
Technologies detected
448
Latest technologies detected value available from the source dataset.
Operating status
Active
Independent Company
Company type
Public Company
type
Ownership status
Public
Ownership Status
Public company
No
Is Public
Company alias
sun pharma
Company Name Alias
Company alias
sun pharmaceutical industries
Company Name Alias
Company alias
sun pharmaceutical industries, inc.
Company Name Alias
Company alias
sun pharmaceutical industries ltd.
Company Name Alias
Company alias
sun pharmaceutical industries, ltd.
Company Name Alias
Website alias
https://www.sunpharma.com
Website Alias
Website alias
https://www.sunpharma.com/
Website Alias
Canonical website
https://www.sunpharma.com
website
Website domain
sunpharma.com
Website Domain
Unique website
Yes
Unique Website
Unique domain
Yes
Unique Domain
Expired domain
No
Expired Domain
LinkedIn shorthand
sun-pharma
Canonical LinkedIn Shorthand Name
Source ID
484735
Source ID
UUID
43NW4MT1WD66HS5FPQRKR6KT31
uuid
SIC code
28
SIC Codes
SIC code
283
SIC Codes
NAICS code
54
NAICS Codes
NAICS code
541
NAICS Codes
Industry
Pharmaceutical Manufacturing
industry
Categories and keywords
['pharmaceutical', 'formulations', 'api', 'us generics', 'speciality brands', 'technically complex formulations', 'quality', 'innovation', 'generic', 'healthcare', 'health', 'drug-development', 'pharma', 'biotechnology']
Categories And Keywords
LinkedIn followers
2.3M
Followers Count LinkedIn
Owler followers
1.4K
Followers Count Owler
Primary location
Sun House, CTS No. 201 B/1,; Western Express Highway, Goregaon East; Mumbai, Maharastra 400063, IN
Office location
SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E); mumbai, Maharashtra, India
Office location
CTS No. 201 B/1; Mumbai, 400063, India
Office location
Mumbai, Maharashtra, India
Office location
Sun House cts no 201 b/1 Western Express Goregaon E Hwy; Mumbai, Maharashtra 400063, India
SUN PHARMA revenue, funding, IPO, and acquisition history
Financial signals are grouped as an analyst-style view: revenue sources, income statement rows, funding rounds, acquisition activity, IPO fields, stock listing context, and ownership structure.
Source 5
$6.2B
Annual revenue
Stock ticker
SUNPHARMA.NS
Operating status
Active
Independent Company
Company type
Public Company
type
Ownership status
Public
Ownership Status
Public company
No
Is Public
Q3, 2026
Q3
Primary value
Revenue: INR 154.7B
Additional metrics
Gross profit: INR 131.5B; EBITDA: INR 53.7B; EBIT: INR 41.5B; Net income: INR 34B; Operating expense: INR 77.8B; Gross margin: 85.0%; EBITDA margin: 34.7%
Q2, 2026
Q2
Primary value
Revenue: INR 144.1B
Additional metrics
Gross profit: INR 119.7B; EBITDA: INR 45.7B; EBIT: INR 38.4B; Net income: INR 31.4B; Operating expense: INR 74B; Gross margin: 83.1%; EBITDA margin: 31.7%
Q1, 2026
Q1
Primary value
Revenue: INR 137.9B
Additional metrics
Gross profit: INR 115B; EBITDA: INR 45.4B; EBIT: INR 30.2B; Net income: INR 23B; Operating expense: INR 69.6B; Gross margin: 83.4%; EBITDA margin: 32.9%
FY, 2025
Fiscal Year
Primary value
Revenue: INR 520.4B
Additional metrics
Gross profit: INR 411.1B; EBITDA: INR 154.3B; EBIT: INR 121.7B; Net income: INR 109.8B; Operating expense: INR 256.9B; Gross margin: 79.0%; EBITDA margin: 29.6%
Q3, 2025
Q3
Primary value
Revenue: INR 134.4B
Additional metrics
Gross profit: INR 114B; EBITDA: INR 46.6B; EBIT: INR 37.1B; Net income: INR 29.2B; Operating expense: INR 67.4B; Gross margin: 84.8%; EBITDA margin: 34.7%
Q2, 2025
Q2
Primary value
Revenue: INR 132.6B
Additional metrics
Gross profit: INR 109.5B; EBITDA: INR 41.6B; EBIT: INR 35.4B; Net income: INR 30.3B; Operating expense: INR 67.9B; Gross margin: 82.6%; EBITDA margin: 31.4%
Q1, 2025
Q1
Primary value
Revenue: INR 125.2B
Additional metrics
Gross profit: INR 105.1B; EBITDA: INR 41.9B; EBIT: INR 35.4B; Net income: INR 28.7B; Operating expense: INR 63.2B; Gross margin: 83.9%; EBITDA margin: 33.5%
FY, 2024
Fiscal Year
Primary value
Revenue: INR 477.6B
Additional metrics
Gross profit: INR 371.7B; EBITDA: INR 132.3B; EBIT: INR 101.8B; Net income: INR 96.5B; Operating expense: INR 239.4B; Gross margin: 77.8%; EBITDA margin: 27.7%
Q3, 2024
Q3
Primary value
Revenue: INR 121.6B
Additional metrics
Gross profit: INR 98.9B; EBITDA: INR 36B; EBIT: INR 29.1B; Net income: INR 25.7B; Operating expense: INR 62.9B; Gross margin: 81.4%; EBITDA margin: 29.6%
Q2, 2024
Q2
Primary value
Revenue: INR 120B
Additional metrics
Gross profit: INR 97B; EBITDA: INR 35.1B; EBIT: INR 28.7B; Net income: INR 24B; Operating expense: INR 61.9B; Gross margin: 80.8%; EBITDA margin: 29.2%
Q1, 2024
Q1
Primary value
Revenue: INR 117.9B
Additional metrics
Gross profit: INR 93.9B; EBITDA: INR 35.3B; EBIT: INR 25.6B; Net income: INR 20.1B; Operating expense: INR 58.5B; Gross margin: 79.7%; EBITDA margin: 30.0%
FY, 2023
Fiscal Year
Primary value
Revenue: INR 432.8B
Additional metrics
Gross profit: INR 326B; EBITDA: INR 119.4B; EBIT: INR 92.4B; Net income: INR 85.6B; Operating expense: INR 206.5B; Gross margin: 75.3%; EBITDA margin: 27.6%
| Period | Primary value | Additional metrics |
|---|---|---|
Q3, 2026 Q3 | Revenue: INR 154.7B | Gross profit: INR 131.5B; EBITDA: INR 53.7B; EBIT: INR 41.5B; Net income: INR 34B; Operating expense: INR 77.8B; Gross margin: 85.0%; EBITDA margin: 34.7% |
Q2, 2026 Q2 | Revenue: INR 144.1B | Gross profit: INR 119.7B; EBITDA: INR 45.7B; EBIT: INR 38.4B; Net income: INR 31.4B; Operating expense: INR 74B; Gross margin: 83.1%; EBITDA margin: 31.7% |
Q1, 2026 Q1 | Revenue: INR 137.9B | Gross profit: INR 115B; EBITDA: INR 45.4B; EBIT: INR 30.2B; Net income: INR 23B; Operating expense: INR 69.6B; Gross margin: 83.4%; EBITDA margin: 32.9% |
FY, 2025 Fiscal Year | Revenue: INR 520.4B | Gross profit: INR 411.1B; EBITDA: INR 154.3B; EBIT: INR 121.7B; Net income: INR 109.8B; Operating expense: INR 256.9B; Gross margin: 79.0%; EBITDA margin: 29.6% |
Q3, 2025 Q3 | Revenue: INR 134.4B | Gross profit: INR 114B; EBITDA: INR 46.6B; EBIT: INR 37.1B; Net income: INR 29.2B; Operating expense: INR 67.4B; Gross margin: 84.8%; EBITDA margin: 34.7% |
Q2, 2025 Q2 | Revenue: INR 132.6B | Gross profit: INR 109.5B; EBITDA: INR 41.6B; EBIT: INR 35.4B; Net income: INR 30.3B; Operating expense: INR 67.9B; Gross margin: 82.6%; EBITDA margin: 31.4% |
Q1, 2025 Q1 | Revenue: INR 125.2B | Gross profit: INR 105.1B; EBITDA: INR 41.9B; EBIT: INR 35.4B; Net income: INR 28.7B; Operating expense: INR 63.2B; Gross margin: 83.9%; EBITDA margin: 33.5% |
FY, 2024 Fiscal Year | Revenue: INR 477.6B | Gross profit: INR 371.7B; EBITDA: INR 132.3B; EBIT: INR 101.8B; Net income: INR 96.5B; Operating expense: INR 239.4B; Gross margin: 77.8%; EBITDA margin: 27.7% |
Q3, 2024 Q3 | Revenue: INR 121.6B | Gross profit: INR 98.9B; EBITDA: INR 36B; EBIT: INR 29.1B; Net income: INR 25.7B; Operating expense: INR 62.9B; Gross margin: 81.4%; EBITDA margin: 29.6% |
Q2, 2024 Q2 | Revenue: INR 120B | Gross profit: INR 97B; EBITDA: INR 35.1B; EBIT: INR 28.7B; Net income: INR 24B; Operating expense: INR 61.9B; Gross margin: 80.8%; EBITDA margin: 29.2% |
Q1, 2024 Q1 | Revenue: INR 117.9B | Gross profit: INR 93.9B; EBITDA: INR 35.3B; EBIT: INR 25.6B; Net income: INR 20.1B; Operating expense: INR 58.5B; Gross margin: 79.7%; EBITDA margin: 30.0% |
FY, 2023 Fiscal Year | Revenue: INR 432.8B | Gross profit: INR 326B; EBITDA: INR 119.4B; EBIT: INR 92.4B; Net income: INR 85.6B; Operating expense: INR 206.5B; Gross margin: 75.3%; EBITDA margin: 27.6% |
Post-IPO Equity
1999-01-01
Checkpoint Therapeutics
$355M
2025-05-30 | Acquisition List Source 1
Checkpoint Therapeutics
$355M
2025-03-09 | Acquisition List Source 2
Checkpoint Therapeutics, Inc.
$335M
2025-03-01 | Acquisition List Source 5
Taro Pharmaceutical
$347.4M
2024-06-24 | Acquisition List Source 1
Kemipharm S.A.
Acquisition
2024-05-01 | Acquisition List Source 5
Valstar S.A.
Acquisition
2024-05-01 | Acquisition List Source 5
Taro Pharmaceutical Industries
Acquisition
2024-01-17 | Acquisition List Source 2
Libra Merger
Acquisition
2024-01-01 | Acquisition List Source 1
Taro Pharmaceutical Industries Ltd.
Acquisition
2024-01-01 | Acquisition List Source 5
Libra Merger Ltd.
Acquisition
2024-01-01 | Acquisition List Source 5
Vivaldis Health And Foods
INR 1.4B
2023-06-30 | Acquisition List Source 1
Concert Pharmaceuticals
$576M
2023-03-06 | Acquisition List Source 1
Vivaldis Health & Foods Pvt. Ltd.
$17.4M
2023-03-01 | Acquisition List Source 5
Concert Pharmaceuticals
$576M
2023-01-19 | Acquisition List Source 2
Pola Pharma
$1M
2018-11-27 | Acquisition List Source 1
POLA-Pharma
Acquisition
2018-11-27 | Acquisition List Source 2
Zenotech Laboratories
INR 855M
2017-07-28 | Acquisition List Source 1
Biosintez
$60M
2016-12-20 | Acquisition List Source 1
OJSC Biosintez
$24M
2016-11-23 | Acquisition List Source 2
Ocular Technologies
$40M
2016-10-27 | Acquisition List Source 1
Ocular Technologies Sarl
$40M
2016-10-27 | Acquisition List Source 2
InSite Vision
$48M
2015-09-15 | Acquisition List Source 1
Ranbaxy Laboratories
INR 190B
2015-03-24 | Acquisition List Source 1
Pharmalucence
Acquisition
2014-07-16 | Acquisition List Source 1
Ranbaxy Laboratories
$3.2B
2014-04-06 | Acquisition List Source 2
DUSA Pharmaceuticals
$230M
2012-11-09 | Acquisition List Source 2
DUSA Pharmaceuticals
$230M
2012-11-08 | Acquisition List Source 1
Universal Enterprises Private Limited
Acquisition
Acquisition List Source 1
Skisen Labs Private Limited
Acquisition
Acquisition List Source 1
Ranbaxy Farmaceutica Ltda.
Acquisition
Acquisition List Source 1
Sun Pharmaceutical Medicare Limited
Acquisition
Acquisition List Source 1
Taro Pharmaceuticals North America, Inc.
Acquisition
Acquisition List Source 1
Sun Pharmaceutical (Bangladesh) Limited
Acquisition
Acquisition List Source 1
Green Eco Development Centre Limited
Acquisition
Acquisition List Source 1
Realstone Multitrade Private Limited
Acquisition
Acquisition List Source 1
Sun Pharma Egypt LLC
Acquisition
Acquisition List Source 1
Alchemee Skincare Corporation
Acquisition
Acquisition List Source 1
Sun Pharma Luxembourg S.A
Acquisition
Acquisition List Source 1
Sun Pharma Holdings UK Limited
Acquisition
Acquisition List Source 1
Sun Pharmaceuticals (EZ) Limited
Acquisition
Acquisition List Source 1
Alkaloida Chemical Company Zrt.
Acquisition
Acquisition List Source 1
Sun Pharma Middle East FZE LLC
Acquisition
Acquisition List Source 1
Sun Laboratories FZE
Acquisition
Acquisition List Source 1
SC Terapia SA
Acquisition
Acquisition List Source 1
JSC Biosintez
Acquisition
Acquisition List Source 1
The Proactiv Company KK
Acquisition
Acquisition List Source 1
Sun Pharma Canada Inc.
Acquisition
Acquisition List Source 1
Alchemee, LLC
Acquisition
Acquisition List Source 1
Sun Pharmaceuticals Holdings USA, Inc.
Acquisition
Acquisition List Source 1
Foundation for Disease Elimination and Control of India
Acquisition
Acquisition List Source 1
Sun Pharma France
Acquisition
Acquisition List Source 1
Sun Pharma Science Foundation
Acquisition
Acquisition List Source 1
Sun Pharma UK Limited
Acquisition
Acquisition List Source 1
Sun Pharmaceuticals Morocco LLC
Acquisition
Acquisition List Source 1
Ranbaxy Signature LLC
Acquisition
Acquisition List Source 1
Sonke Pharmaceuticals Proprietary Limited
Acquisition
Acquisition List Source 1
Sun Pharmaceutical Industries S.A.C.
Acquisition
Acquisition List Source 1
Ranbaxy Pharmaceuticals Ukraine LLC
Acquisition
Acquisition List Source 1
Rexcel Egypt LLC
Acquisition
Acquisition List Source 1
Ohm Laboratories, Inc.
Acquisition
Acquisition List Source 1
Ranbaxy Pharmaceuticals (Pty) Ltd
Acquisition
Acquisition List Source 1
Concert Pharma Ireland Limited
Acquisition
Acquisition List Source 1
Vivaldis Health and Foods Private Limited
Acquisition
Acquisition List Source 1
Ranbaxy Nigeria Limited
Acquisition
Acquisition List Source 1
Sun Pharma Holdings
Acquisition
Acquisition List Source 1
Taro Pharma Corporation, Inc.
Acquisition
Acquisition List Source 1
Sun Pharma Distributors Limited
Acquisition
Acquisition List Source 1
Sun Farmaceutica do Brasil Ltda.
Acquisition
Acquisition List Source 1
Sun Pharmaceuticals Germany GmbH
Acquisition
Acquisition List Source 1
Ranbaxy (Thailand) Co., Ltd.
Acquisition
Acquisition List Source 1
Snoopy Merger Sub, Inc.
Acquisition
Acquisition List Source 1
Sun Pharma Philippines, Inc.
Acquisition
Acquisition List Source 1
AO Ranbaxy
Acquisition
Acquisition List Source 1
Antibe Therapeutics Inc.
Acquisition
Acquisition List Source 1
Aditya Acquisition Company Ltd.
Acquisition
Acquisition List Source 1
Sun Pharma East Africa Limited
Acquisition
Acquisition List Source 1
Ranbaxy (Malaysia) SDN. BHD.
Acquisition
Acquisition List Source 1
Sun Pharma Switzerland Ltd.
Acquisition
Acquisition List Source 1
Sun Pharmaceutical Industries, Inc.
Acquisition
Acquisition List Source 1
Softdeal Pharmaceutical Private Limited
Acquisition
Acquisition List Source 1
Basics GmbH
Acquisition
Acquisition List Source 1
Sun Pharmaceuticals North Africa SA
Acquisition
Acquisition List Source 1
Zenotech Laboratories Limited
Acquisition
Acquisition List Source 1
Sun Pharma De Mexico S.A. DE C.V.
Acquisition
Acquisition List Source 1
Realstone Infra Limited
Acquisition
Acquisition List Source 1
Sun Pharmaceutical Industries (Australia) Pty Limited
Acquisition
Acquisition List Source 1
Taro Pharmaceutical Industries Ltd. (Taro)
Acquisition
Acquisition List Source 1
Sun Pharma ANZ Pty Ltd
Acquisition
Acquisition List Source 1
Sun Pharmaceutical Peru S.A.C.
Acquisition
Acquisition List Source 1
Sun Pharma (Netherlands) B.V.
Acquisition
Acquisition List Source 1
PI Real Estate Ventures, LLC
Acquisition
Acquisition List Source 1
Taro Pharmaceuticals U.S.A., Inc.
Acquisition
Acquisition List Source 1
Sun Pharma Laboratorios,S.L.U.
Acquisition
Acquisition List Source 1
Ranbaxy South Africa (Pty) Ltd
Acquisition
Acquisition List Source 1
Sun Pharma De Venezuela, C.A.
Acquisition
Acquisition List Source 1
Caraco Pharmaceuticals Private Limited
Acquisition
Acquisition List Source 1
Faststone Mercantile Company Private Limited
Acquisition
Acquisition List Source 1
Sun Pharma Laboratories Limited
Acquisition
Acquisition List Source 1
Taro Pharmaceuticals Europe B.V.
Acquisition
Acquisition List Source 1
Sun Pharma (Shanghai) Co.,Ltd
Acquisition
Acquisition List Source 1
Sun Pharma Italia srl
Acquisition
Acquisition List Source 1
The Proactiv Company Holdings, Inc.
Acquisition
Acquisition List Source 1
Proactiv YK
Acquisition
Acquisition List Source 1
Chattem Chemicals Inc.
Acquisition
Acquisition List Source 1
Sun Pharma Japan Ltd.
Acquisition
Acquisition List Source 1
Taro Pharmaceuticals Inc.
Acquisition
Acquisition List Source 1
Taro International Ltd.
Acquisition
Acquisition List Source 1
Ranbaxy (Poland) SP. ZO.O.
Acquisition
Acquisition List Source 1
Sun Pharma Community Healthcare Society
Acquisition
Acquisition List Source 1
Ranbaxy Inc.
Acquisition
Acquisition List Source 1
Neetnav Real Estate Private Limited
Acquisition
Acquisition List Source 1
Sun Pharmaceutical Industries (Europe) B.V.
Acquisition
Acquisition List Source 1
The Taro Development Corporation
Acquisition
Acquisition List Source 1
Web visibility, demand, and topics
Use these signals to understand discoverability, demand quality, search interest, and audience fit.
Monthly visits
240.9K
Latest monthly visits value available from the source dataset.
Global web rank
#157,584
Lower rank values indicate stronger web visibility in the source dataset.
Bounce rate
44.0%
Latest bounce rate value available from the source dataset.
Pages per visit
3.72
Latest pages per visit value available from the source dataset.
Average visit duration
1m 17s
Latest average visit duration value available from the source dataset.
Estimated monthly page views
896.2K
Derived estimate calculated as monthly visits multiplied by pages per visit.
sun pharma
Associated search topic
sunpharma
Associated search topic
sun pharma company
Associated search topic
sun pharmaceutical industries ltd
Associated search topic
sun pharmaceutical industries
Associated search topic
LinkedIn followers
2.3M
Followers Count LinkedIn
Owler followers
1.4K
Followers Count Owler
Employees, hiring, attrition, and compensation
This section groups org scale, hiring motion, employee movement, department mix, and salary benchmarks so teams can qualify operating momentum and budget signals.
Employees
46.2K
Latest employees value available from the source dataset.
Inferred employees
17K
Latest inferred employees value available from the source dataset.
Open roles
414
Latest open roles value available from the source dataset.
Departures
0
Latest departures value available from the source dataset.
Employee attrition rate
0.0%
Latest employee attrition rate value available from the source dataset.
Hiring intensity
9.0 roles / 1K employees
Derived signal showing open roles normalized by employee count.
Territory Manager, Ophthalmics - Edmonton
Open role
4405340367
Senior Manager, Training and Development
Open role
4407910973
SME- Packing
Open role
4355326080
Key Account Manager - Ethical
Open role
4401269965
Territory Manager, LTC (Houston, TX)
Open role
4400215852
Business Analyst
Open role
4399015628
Senior Brand Manager, Marketing - Medical Dermatology, Princeton, NJ - Hybrid
Open role
4367619764
Category Manager - Prohance
Open role
4403737342
Showing 8 of 18 available records.
Showing 8 of 10 available records.
Showing 8 of 10 available records.
Assistant Manager, Analytical R&D
USD $103.6K
Annual
Senior Regulatory Affairs Associate
USD $116.4K
Annual
IT Manager
INR $12.2M
Annual | Updated 2023-01-11
Analista De Garantia De Qualidade Pleno
BRL $70.2K
Monthly | Updated 2024-03-20
Coordenador Comercial
BRL $75K
Monthly | Updated 2021-01-12
Senior Medical Representative
INR $660K
Monthly | Updated 2024-09-10
Medical Representative PSR
INR $450K
Monthly | Updated 2023-05-01
Senior Account Manager
USD $105.2K
Annual
Showing 8 of 10 available records.
Assistant Manager, Research & Development
Cash Bonus $7K
Annual
Chemist-manufacturing
Cash Bonus $5K
Annual
Manufacturing Supervisor
Cash Bonus $4.3K
Annual
QA Manager
Cash Bonus $9.4K
Annual
Laboratory Chemist
Cash Bonus $3K
Annual
Quality Assurance Chemist
Cash Bonus $3.9K
Annual
Engineer (Plant Engineer)
Cash Bonus $5.5K
Annual
Manufacturing Chemist
Cash Bonus $4.2K
Annual
Showing 8 of 10 available records.
Senior Medical Representative
INR $727K
Monthly | Updated 2024-09-10
Trainee Sales Executive
INR $310K
Annual | Updated 2024-09-07
Marketing
INR $889.8K
Annual | Updated 2024-08-11
Manager 2
INR $1.1M
Annual | Updated 2024-08-06
QA Officer
INR $186.5K
Monthly | Updated 2024-08-04
QC Microbiologist
INR $225K
Monthly | Updated 2024-08-04
Analista
BRL $54K
Monthly | Updated 2024-08-04
Senior Marketing Manager
INR $3.5M
Annual | Updated 2024-07-11
Showing 8 of 10 available records.
Product readiness, customer proof, and employee sentiment
Product availability, public reviews, and employee sentiment help visitors understand whether the company is mature, documented, reviewable, and operationally healthy.
Employee reviews
1.5K
Latest employee reviews value available from the source dataset.
Employee rating
3.5
Latest review score available from the source dataset.
Technology, leadership, competitors, funding, and corporate activity
These data points help sales, partnerships, analysts, and researchers understand how the company operates, who surrounds it, and where it may be moving next.
Totalchrom
Verified technology
Last verified 2026-05-04 | First seen 2025-08-17
Rtbs
Verified technology
Last verified 2026-05-04 | First seen 2025-12-15
Operative
Verified technology
Last verified 2026-05-04 | First seen 2024-05-20
Brocade
Verified technology
Last verified 2026-05-04 | First seen 2025-02-18
Power Bi
Verified technology
Last verified 2026-05-04 | First seen 2025-08-17
Tds
Verified technology
Last verified 2026-05-04 | First seen 2025-08-17
Prototype
Verified technology
Last verified 2026-05-04 | First seen 2024-05-20
Siemens
Verified technology
Last verified 2026-05-04 | First seen 2025-08-17
Showing 8 of 24 available records.
Showing 8 of 12 available records.
Brijrajsinh Jhala
Human Resources Project Lead
Shweta Subramanian
Executive
Anish kumar Singh
Executive
Shrikant Pandey
Head Of Quality Control
Ruhan Amin
Executive
Kartikey Pathak
Executive
DINESH NAIDU
Associate Vice President
Sayantan Chatterjee
Executive
Showing 8 of 12 available records.
Akshay Mhatre
Global IT Infrastructure Architecture Leader
Dec 2025
Ankit Vora
Executive
Dec 2025
Pradeep Saini
Executive
Feb 2026
Samiran Saha
Site EHS Head
Mar 2026
Vishal Joshi
Head of Engineering
Feb 2026
John Chan
Business Unit Head
Apr 2026
Abhilesh Kumar
Executive
Apr 2026
Anis Patel
Executive
Feb 2026
Pratik Chaudhary
Executive
Apr 2026
Venkateswara Reddy
Head of Quality Control
Dec 2025
Andy Nelson
Vice President Sales Marketing Dermatology
Dec 2025
pradeep patel
Executive
Apr 2026
Swati Suman
Executive
Dec 2025
Manankumar Patel
Executive
Mar 2026
Jobanpreet singh Sharah
Executive
May 2026
Himanshu Chavda
Executive
Feb 2026
Primary location
Sun House, CTS No. 201 B/1,; Western Express Highway, Goregaon East; Mumbai, Maharastra 400063, IN
Office location
SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E); mumbai, Maharashtra, India
Office location
CTS No. 201 B/1; Mumbai, 400063, India
Office location
Mumbai, Maharashtra, India
Office location
Sun House cts no 201 b/1 Western Express Goregaon E Hwy; Mumbai, Maharashtra 400063, India
Kidney stones may start small, but once they occur, the likelihood of recurrence is high. Preventive measures…
72 reactions; 1 comments
2026-04-28 | Kidney stones may start small, but once they occur, the likelihood of recurrence is high. Preventive measures such as maintaining hydration, limiting excess salt, and following medical advice on diet and lifestyle can s…
In our last poll, we asked which of these can be a sign of dehydration. A dehydration headache is one way the…
115 reactions; 4 comments
2026-04-27 | In our last poll, we asked which of these can be a sign of dehydration. A dehydration headache is one way the body may respond when fluid levels fall. It can come with other signs such as fatigue, dry mouth, intense thi…
Sun Pharma has signed a definitive agreement to acquire Organon, a US-headquartered global healthcare company…
3.2K reactions; 181 comments
2026-04-27 | Sun Pharma has signed a definitive agreement to acquire Organon, a US-headquartered global healthcare company. This strategic move will strengthen our Innovative Medicines and Branded Generics portfolio, while establish…
The world knows a No. 1 team when it sees one. But every team also has its own No. 1s within it. We asked Roy…
192 reactions; 2 comments
2026-04-24 | The world knows a No. 1 team when it sees one. But every team also has its own No. 1s within it. We asked Royal Challengers Bengaluru to pick theirs. Here is how it went. #SunPharma #RapidFire #NumberOneMindset
In summer, fluid loss can build gradually and show up through symptoms that may be easy to miss. #SunPharma…
154 reactions; 9 comments
2026-04-23 | In summer, fluid loss can build gradually and show up through symptoms that may be easy to miss. #SunPharma #SummerWellness #Poll
The body relies on both the heart and muscle movement to maintain healthy circulation. Activities like walkin…
151 reactions; 3 comments
2026-04-22 | The body relies on both the heart and muscle movement to maintain healthy circulation. Activities like walking activate the muscles in the lower legs, helping support blood flow after long periods of sitting or inactivi…
SIC code
28
SIC Codes
SIC code
283
SIC Codes
NAICS code
54
NAICS Codes
NAICS code
541
NAICS Codes
Industry
Pharmaceutical Manufacturing
industry
Categories and keywords
['pharmaceutical', 'formulations', 'api', 'us generics', 'speciality brands', 'technically complex formulations', 'quality', 'innovation', 'generic', 'healthcare', 'health', 'drug-development', 'pharma', 'biotechnology']
Categories And Keywords
SUN PHARMA FAQs
Company profile
Want verified contact data for SUN PHARMA?
Datakart.ai gives you verified email addresses, direct dials, and buying intent signals for key decision-makers at SUN PHARMA and 1,700+ other companies.